[1]
“Estimation of Serum Interleukin-6 level as a Useful Marker for Clinical Severity of Sickle Cell Disease among Sudanese Patients”, Int. J. Multidiscip. Curr. Res., vol. 5, no. 3, pp. 642–644, May 2017, doi: 10.14741/ijmcr/v.5.3.20.